Protein kinases of the Hippo pathway: Regulation and substrates

Seminars in Cell and Developmental Biology

Volumn 23, Issue 7, 2012, Pages 770-784

  Avruch, Joseph ^a,b   Zhou, Dawang ^c   Fitamant, Julien ^a,b   Bardeesy, Nabeel ^a,b   Mou, Fan ^a,b   Barrufet, Laura Regué ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c XIAMEN UNIVERSITY   (China)

Author keywords

Hippo; Lats1 2; Mob1; Mst1 2; Ndr1 2; Protein kinase

Indexed keywords

FOXO3 PROTEIN; HIPPO PROTEIN; LATS PROTEIN; LATS1 PROTEIN; LATS2 PROTEIN; MOB1A PROTEIN; MOB1B PROTEIN; MST1 PROTEIN; MST2 PROTEIN; NDR1 PROTEIN; NDR2 PROTEIN; PHOSPHOTRANSFERASE; POLYPEPTIDE; PROTEIN; PROTEIN KINASE B; RAF1 PROTEIN; RASSF POLYPEPTIDE; SALVADOR PROTEIN; TAO KINASE; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; WARTS PROTEIN; WW45 PROTEIN;

APOPTOSIS; CAENORHABDITIS ELEGANS; CARBOXY TERMINAL SEQUENCE; DOWN REGULATION; GENE DELETION; GENE MUTATION; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

MAMMALIA; METAZOA; MURINAE; SACCHAROMYCES CEREVISIAE;

EID: 84866601389     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2012.07.002     Document Type: Review

References (169)

1. Watson K.L., Justice R.W., Bryant P.J. Drosophilia in cancer research: the first fifty tumor suppressor genes. Journal of Cell Science. Supplement 1994, 18:19-33.
2. Xu T., Rubin G.M. Analysis of genetic mosaics in developing and adult Drosophila tissues. Development 1993, 1223-1237.
3. Justice R.W., Zilian O., Woods D.F., Noll M., Bryant P.J. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes and Development 1995, 9:534-546.
4. Xu T., Wang W., Zhang S., Stewart R.A., Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development 1995, 121:53-63.
5. Tao W., Zhang S., Turenchalk G.S., Stewart R.A., St John M.A., Chen W., et al. Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity. Nature Genetics 1999, 21:177-181.
6. Yabuta N., Fujii T., Copeland N.G., Gilbert D.J., Jenkins N.A., Nishiguchi H., et al. Structure, expression, and chromosome mapping of LATS2, a mammalian homologue of the Drosophila tumor suppressor gene lats/warts. Genomics 2000, 63:263-270.
7. Hori T., Takaori-Kondo A., Kamikubo Y., Uchiyama T. Molecular cloning of a novel human protein kinase, kpm, that is homologous to warts/lats, a Drosophila tumor suppressor. Oncogene 2000, 19:3101-3109.
8. St John M.A., Tao W., Fei X., Fukumoto R., Carcangiu M.L., Brownstein D.G. Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nature Genetics 1999, 21:182-186.
9. Tapon N., Harvey K.F., Bell D.W., Wahrer D.C., Schiripo T.A., Haber D.A., et al. salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 2002, 110:467-478.
10. Kango-Singh M., Nolo R., Tao C., Verstreken P., Hiesinger P.R., Bellen H.J., et al. Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development 2002, 129:5719-5730.
11. Wu S., Huang J., Dong J., Pan D. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 2003, 114(4):445-456.
12. Harvey K.F., Pfleger C.M., Hariharan I.K. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 2003, 114:457-467.
13. Udan R.S., Kango-Singh M., Nolo R., Tao C., Halder G. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nature Cell Biology 2003, 5:914-920.
14. Pantalacci S., Tapon N., Léopold P. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nature Cell Biology 2003, 5:921-927.
15. Jia J., Zhang W., Wang B., Trinko R., Jiang J. The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes and Development 2003, 17:2514-2519.
16. Dan I., Watanabe N.M., Kusumi A. The Ste20 group kinases as regulators of MAP kinase cascades. Trends in Cell Biology 2001, 11:220-230.
17. Lai Z.C., Wei X., Shimizu T., Ramos E., Rohrbaugh M., Nikolaidis N., et al. Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 2005, 120:675-685.
18. Praskova M., Xia F., Avruch J. MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Current Biology 2008, 18:311-321.
19. Huang J., Wu S., Barrera J., Matthews K., Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 2005, 122:421-434.
20. Grusche F.A., Richardson H.E., Harvey K.F. Upstream regulation of the Hippo size control pathway. Current Biology 2010, 20:R574-R582. [Review].
21. Yin M., Zhang L. Hippo signaling: a hub of growth control, tumor suppression and pluripotency maintenance. Journal of Genetics and Genomics 2011, 38:471-481.
22. Enomoto M., Igaki T. Deciphering tumor-suppressor signaling in flies: genetic link between Scribble/Dlg/Lgl and the Hippo pathways. Journal of Genetics and Genomics 2011, 38:461-470.
23. Lei Q.Y., Zhang H., Zhao B., Zha Z.Y., Bai F., Pei X.H., et al. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the Hippo pathway. Molecular and Cellular Biology 2008, 28:2426-2436.
24. Zhao B., Wei X., Li W., Udan R.S., Yang Q., Kim J., et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes and Development 2007, 21:2747-2761.
25. Zhou D., Conrad C., Xia F., Park J.S., Payer B., Yin Y., et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 2009, 16:425-438.
26. Lee J.H., Kim T.S., Yang T.H., Koo B.K., Oh S.P., Lee K.P., et al. A crucial role of WW45 in developing epithelial tissues in the mouse. EMBO Journal 2008, 27(8):1231-1242.
27. Song H., Mak K.K., Topol L., Yun K., Hu J., Garrett L., et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:1431-1436.
28. Lu L., Li Y., Kim S.M., Bossuyt W., Liu P., Qui Q., et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(January (4)):1437-1442.
29. Lee K.P., Lee J.H., Kim T.S., Kim T.H., Park H.D., Byun J.S., et al. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:8248-8253.
30. Cai J., Zhang N., Zheng Y., de Wilde R.F., Maitra A., Pan D. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes and Development 2010, 24(November):2383-2388.
31. Schlegelmilch K., Mohseni M., Kirak O., Pruszak J., Rodriguez J.R., Zhou D., et al. Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell 2001, 144:782-795.
32. Zhou D., Zhang Y., Wu H., Barry E., Yin Y., Lawrence E., et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:E1312-E1320.
33. Cao X., Pfaff S.L., Gage F.H. YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes and Development 2008, 22:3320-3334.
34. Emoto K., Parrish J.Z., Jan L.Y., Jan Y.N. The tumour suppressor Hippo acts with the NDR kinases in dendritic tiling and maintenance. Nature 2006, 443:210-213.
35. Millward T.A., Hess D., Hemmings B.A. Ndr protein kinase is regulated by phosphorylation on two conserved sequence motifs. Journal of Biological Chemistry 1999, 274:33847-33850.
36. Hergovich A., Hemmings B.A. Mammalian NDR/LATS protein kinases in Hippo tumor suppressor signaling. Biofactors 2009, 35:338-345.
37. Cornils H., Kohler R.S., Hergovich A., Hemmings B.A. Downstream of human NDR kinases: impacting on c-myc and p21 protein stability to control cell cycle progression. Cell Cycle 2011, 10:1897-1904.
38. Abdollahpour H., Appaswamy G., Kotlarz D., Diestelhorst J., Beier R., Schäffer A.A., et al. The phenotype of human STK4 deficiency. Blood 2012, 119:3450-3457.
39. Nehme N.T., Pachlopnik Schmid J., Debeurme F., André-Schmutz I., Lim A., Nitschke P., et al. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T cells survival. Blood 2012, 119:3458-3468.
40. Zhou D., Medoff B.D., Chen L., Li L., Zhang X.F., Praskova M., et al. The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:20321-20326.
41. Katagiri K., Katakai T., Ebisuno Y., Ueda Y., Okada T., Kinashi T., et al. Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes. EMBO Journal 2009, 28:1319-1331.
42. Dong Y., Du X., Ye J., Han M., Xu T., Zhuang Y., et al. A cell-intrinsic role for Mst1 in regulating thymocyte egress. Journal of Immunology 2009, 183:3865-3872.
43. Choi J., Oh S., Lee D., Oh H.J., Park J.Y., Lee S.B., et al. Mst1-FoxO signaling protects Naïve T lymphocytes from cellular oxidative stress in mice. PLoS One 2009, 4:e8011.
44. Mou F., Praskova M., Xia F., Van Buren D., Hock H., Avruch J., et al. The MST1 and Mst2 kinases control activation of rho family GTPases and thymic egress of mature thymocytes. Journal of Experimental Medicine 2012, 209:741-759.
45. Creasy C.L., Chernoff J. Cloning and characterization of a human protein kinase with homology to Ste20. Journal of Biological Chemistry 1995, 270:21695-21700.
46. Creasy C.L., Chernoff J. Cloning and characterization of a member of the MST subfamily of Ste20-like kinases. Gene 1995, 167:303-306.
47. Taylor L.K., Wang H.C., Erikson R.L. Newly identified stress-responsive protein kinases, Krs-1 and Krs-2. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:10099-10104.
48. Wang H.C., Erikson R.L. Activation of protein serine/threonine kinases p42, p63, and p87 in Rous sarcoma virus-transformed cells: signal transduction/transformation-dependent MBP kinases. Molecular Biology of the Cell 1992, 3:1329-1337.
49. Creasy C.L., Ambrose D.M., Chernoff J. The Ste20-like protein kinase, Mst1, dimerizes and contains an inhibitory domain. Journal of Biological Chemistry 1996, 271:21049-21053.
50. Jin Y., Dong L., Lu Y., Wu W., Hao Q., Zhou J., et al. Dimerization and cytoplasmic localization regulate Hippo kinase signaling activity in organ size control. Journal of Biological Chemistry 2012, 287:5784-5796.
51. Scheel H., Hofmann K. A novel interaction motif. SARAH, connects three classes of tumor suppressor. Current Biology 2003, 13:R899-R900.
52. Hwang E., Ryu K.S., Pääkkönen K., Güntert P., Cheong H.K., Lim D.S., et al. Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:9236-9241.
53. Avruch J., Xavier R., Bardeesy N., Zhang X.F., Praskova M., Zhou D., et al. Rassf family of tumor suppressor polypeptides. Journal of Biological Chemistry 2009, 284:11001-11005.
54. Praskova M., Khoklatchev A., Ortiz-Vega S., Avruch J. Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochemical Journal 2004, 381(Pt 2):453-462.
55. Katagiri K., Imamura M., Kinashi T. Spatiotemporal regulation of the kinase Mst1 by binding protein RAPL is critical for lymphocyte polarity and adhesion. Nature Immunology 2006, 7:919-928.
56. Polesello C., Huelsmann S., Brown N.H., Tapon N. The Drosophila RASSF homolog antagonizes the Hippo pathway. Current Biology 2006, 16:2459-2465.
57. Guo C., Tommasi S., Liu L., Yee J.K., Dammann R., Pfeifer G.P. RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. Current Biology 2007, 17:700-705.
58. Donninger H., Allen N., Henson A., Pogue J., Williams A., Gordon L., et al. Salvador protein is a tumor suppressor effector of RASSF1A with Hippo pathway-independent functions. Journal of Biological Chemistry 2011, 286:18483-18491.
59. Cooper W.N., Hesson L.B., Matallanas D., Dallol A., von Kriegsheim A., Ward R., et al. RASSF2 associates with and stabilizes the proapoptotic kinase MST2. Oncogene 2009, 28:2988-2998.
60. Graves J.D., Gotoh Y., Draves K.E., Ambrose D., Han D.K., Wright M., et al. Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO Journal 1998, 17:2224-2234.
61. Lee K.K., Ohyama T., Yajima N., Tsubuki S., Yonehara S. MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. Journal of Biological Chemistry 2001, 276:19276-19285.
62. Reszka A.A., Halasy-Nagy J.M., Masarachia P.J., Rodan G.A. Isphosphonates act directly on the osteoclast to induce caspase cleavage of mst1 kinase during apoptosis. A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase. Journal of Biological Chemistry 1999, 274:34967-34973.
63. Song J.J., Lee Y.J. Differential cleavage of Mst1 by caspase-7/-3 is responsible for TRAIL-induced activation of the MAPK superfamily. Cellular Signalling 2008, 20:892-906.
64. Lin Y., Khokhlatchev A., Figeys D., Avruch J. Death-associated protein 4 binds MST1 and augments MST1-induced apoptosis. Journal of Biological Chemistry 2002, 277:47991-48001.
65. Glantschnig H., Rodan G.A., Reszka A.A. Mapping of MST1 kinase sites of phosphorylation. Activation and autophosphorylation. Journal of Biological Chemistry 2002, 277:42987-42996.
66. Ura S., Masuyama N., Graves J.D., Gotoh Y. Caspase cleavage of MST1 promotes nuclear translocation and chromatin condensation. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:10148-10153.
67. Anand R., Kim A.Y., Brent M., Marmorstein R. Biochemical analysis of MST1 kinase: elucidation of a C-terminal regulatory region. Biochemistry 2008, 47:6719-6726.
68. Fernando P., Kelly J.F., Balazsi K., Slack R.S., Megeney L.A. Caspase 3 activity is required for skeletal muscle differentiation. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:11025-11030.
69. Murray T.V., McMahon J.M., Howley B.A., Stanley A., Ritter T., Mohr A., et al. A non-apoptotic role for caspase-9 in muscle differentiation. Cell Science 2008, 121(Pt 22):3786-3793.
70. Yi C.H., Yuan J. The Jekyll and Hyde functions of caspases. Developmental Cell 2009, 16:21-34.
71. Park B.H., Lee Y.H. Phosphorylation of SAV1 by mammalian ste20-like kinase promotes cell death. BMB Reports 2011, 44:584-589.
72. Roig J., Mikhailov A., Belham C., Avruch J. Nercc1, a mammalian NIMA-family kinase, binds the Ran GTPase and regulates mitotic progression. Genes and Development 2002, 16:1640-1658.
73. Bertran M.T., Sdelci S., Regué L., Avruch J., Caelles C., Roig J. Nek9 is a Plk1-activated kinase that controls early centrosome separation through Nek6/7 and Eg5. EMBO Journal 2011, 30:2634-2647.
74. Dérijard B., Raingeaud J., Barrett T., Wu I.H., Han J., Ulevitch R.J., et al. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 1995, 267:682-685.
75. Ge B., Gram H., Di Padova F., Huang B., New L., Ulevitch R.J., et al. MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha. Science 2002, 295:1291-1294.
76. Boggiano J.C., Vanderzalm P.J., Fehon R.G. Tao-1 phosphorylates Hippo/MST kinases to regulate the Hippo-Salvador-Warts tumor suppressor pathway. Developmental Cell 2011, 21:888-895.
77. Poon C.L., Lin J.I., Zhang X., Harvey K.F. The sterile 20-like kinase Tao-1 controls tissue growth by regulating the Salvador-Warts-Hippo pathway. Developmental Cell 2011, 21:896-906.
78. Guertin D.A., Chang L., Irshad F., Gould K.L., McCollum D. The role of the sid1p kinase and cdc14p in regulating the onset of cytokinesis in fission yeast. EMBO Journal 2000, 19:1803-1815.
79. Hou M.C., Salek J., McCollum D. Mob1p interacts with the Sid2p kinase and is required for cytokinesis in fission yeast. Current Biology 2000, 10:619-622.
80. Hou M.C., Guertin D.A., McCollum D. Initiation of cytokinesis is controlled through multiple modes of regulation of the Sid2p-Mob1p kinase complex. Molecular and Cellular Biology 2004, 24:3262-3276.
81. Hutchison M., Berman K.S., Cobb M.H. Isolation of TAO1, a protein kinase that activates MEKs in stress-activated protein kinase cascades. Journal of Biological Chemistry 1998, 273:28625-28632.
82. Chen Z., Hutchison M., Cobb M.H. Isolation of the protein kinase TAO2 and identification of its mitogen-activated protein kinase/extracellular signal-regulated kinase kinase binding domain. Journal of Biological Chemistry 1999, 274:28803-28807.
83. Tassi E., Biesova Z., Di Fiore P.P., Gutkind J.S., Wong W.T. Human JIK, a novel member of the STE20 kinase family that inhibits JNK and is negatively regulated by epidermal growth factor. Journal of Biological Chemistry 1999, 274:33287-33295.
84. Moore T.M., Garg R., Johnson C., Coptcoat M.J., Ridley A.J., Morris J.D. PSK, a novel STE20-like kinase derived from prostatic carcinoma that activates the c-Jun N-terminal kinase mitogen-activated protein kinase pathway and regulates actin cytoskeletal organization. Journal of Biological Chemistry 2000, 275:4311-4322.
85. Timm T., Li X.Y., Biernat J., Jiao J., Mandelkow E., Vandekerckhove J., et al. MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1. EMBO Journal 2003, 22:5090-5101.
86. Liu T., Rohn J.L., Picone R., Kunda P., Baum B. Tao-1 is a negative regulator of microtubule plus-end growth. Journal of Cell Science 2010, 123:2708-2716.
87. Draviam V.M., Stegmeier F., Nalepa G., Sowa M.E., Chen J., Liang A., et al. A functional genomic screen identifies a role for TAO1 kinase in spindle-checkpoint signalling. Nature Cell Biology 2007, 9:556-564.
88. Densham R.M., O'Neill E., Munro J., König I., Anderson K., Kolch W., et al. MST kinases monitor actin cytoskeletal integrity and signal via c-Jun N-terminal kinase stress-activated kinase to regulate p21Waf1/Cip1 stability. Molecular and Cellular Biology 2009, 29:6380-6390.
89. Sansores-Garcia L., Bossuyt W., Wada K., Yonemura S., Tao C., Sasaki H., et al. Modulating F-actin organization induces organ growth by affecting the Hippo pathway. EMBO Journal 2011, 30:2325-2335.
90. Zhao B., Li L., Wang L., Wang C.Y., Yu J., Guan K.L. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes and Development 2012, 26:54-68.
91. Underhill-Day N., Hill V., Latif F. N-terminal RASSF family: RASSF7-RASSF10. Epigenetics 2011, 6:284-292.
92. Vavvas D., Li X., Avruch J., Zhang X.F. Identification of Nore1 as a potential Ras effector. Journal of Biological Chemistry 1998, 273:5439-5442.
93. Ortiz-Vega S., Khokhlatchev A., Nedwidek M., Zhang X.F., Dammann R., Pfeifer G.P., et al. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene 2002, 21:1381-1390.
94. Dammann R., Li C., Yoon J.H., Chin P.L., Bates S., Pfeifer G.P. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nature Genetics 2000, 25:315-319.
95. Donninger H., Vos M.D., Clark G.J. The RASSF1A tumor suppressor. Journal of Cell Science 2007, 120:3163-3172.
96. Khokhlatchev A., Rabizadeh S., Xavier R., Nedwidek M., Chen T., Zhang X.F., et al. Identification of a novel Ras-regulated proapoptotic pathway. Current Biology 2002, 12:253-265.
97. Duronio V. The life of a cell: apoptosis regulation by the PI3K/PKB pathway. Biochemical Journal 2008, 415:333-344.
98. Matallanas D., Romano D., Al-Mulla F., O'Neill E., Al-Ali W., Crespo P., et al. Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras. Molecular Cell 2011, 44:893-906.
99. Katagiri K., Maeda A., Shimonaka M., Kinashi T. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nature Immunology 2003, 4:741-748.
100. Katagiri K., Ohnishi N., Kabashima K., Iyoda T., Takeda N., Shinkai Y., et al. Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking. Nature Immunology 2004, 5:1045-1051.
101. Kinashi T. Integrin regulation of lymphocyte trafficking: lessons from structural and signaling studies. Advances in Immunology 2007, 93:185-227.
102. Park J., Kang S.I., Lee S.Y., Zhang X.F., Kim M.S., Beers L.F., et al. Tumor suppressor ras association domain family 5 (RASSF5/NORE1) mediates death receptor ligand-induced apoptosis. Journal of Biological Chemistry 2010, 285:35029-35038.
103. Avruch J., Khokhlatchev A., Kyriakis J.M., Luo Z., Tzivion G., Vavvas D., et al. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. Recent Progress in Hormone Research 2001, 56:127-155.
104. Matallanas D., Birtwistle M., Romano D., Zebisch A., Rauch J., von Kriegsheim A., et al. Raf family kinases: old dogs have learned new tricks. Genes Cancer 2011, 2:232-260.
105. Vos M.D., Ellis C.A., Bell A., Birrer M.J., Clark G.J. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. Journal of Biological Chemistry 2000, 275:35669-35672.
106. Wohlgemuth S., Kiel C., Krämer A., Serrano L., Wittinghofer F., Herrmann C. Recognizing and defining true Ras binding domains I: biochemical analysis. Journal of Molecular Biology 2005, 348:741-758.
107. Oh H.J., Lee K.K., Song S.J., Jin M.S., Song M.S., Lee J.H., et al. Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis. Cancer Research 2006, 66:2562-2569.
108. Matallanas D., Romano D., Yee K., Meissl K., Kucerova L., Piazzolla D., et al. RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Molecular Cell 2007, 27:962-975.
109. Vichalkovski A., Gresko E., Cornils H., Hergovich A., Schmitz D., Hemmings B.A. NDR kinase is activated by RASSF1A/MST1 in response to Fas receptor stimulation and promotes apoptosis. Current Biology 2008, 18:1889-1895.
110. Foley C.J., Freedman H., Choo S.L., Onyskiw C., Fu N.Y., Yu V.C., et al. Dynamics of RASSF1A/MOAP-1 association with death receptors. Molecular and Cellular Biology 2008, 28:4520-4535.
111. Gordon M., Baksh S. RASSF1A: not a prototypical Ras effector. Small GTPases 2011, 2:148-157.
112. Wojnowski L., Stancato L.F., Zimmer A.M., Hahn H., Beck T.W., Larner A.C., et al. Craf-1 protein kinase is essential for mouse development. Mechanisms of Development 1998, 76:141-149.
113. Mikula M., Schreiber M., Husak Z., Kucerova L., Rüth J., Wieser R., et al. Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO Journal 2001, 20:1952-1962.
114. Hüser M., Luckett J., Chiloeches A., Mercer K., Iwobi M., Giblett S., et al. MEK kinase activity is not necessary for Raf-1 function. EMBO Journal 2001, 20:1940-1951.
115. O'Neill E., Rushworth L., Baccarini M., Kolch W. Role of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1. Science 2004, 306:2267-2270.
116. Chen J., Fujii K., Zhang L., Roberts T., Fu H. Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:7783-7788.
117. Ehrenreiter K., Piazzolla D., Velamoor V., Sobczak I., Small J.V., Takeda J., et al. Raf-1 regulates Rho signaling and cell migration. Journal of Cell Biology 2005, 168:955-964.
118. Niault T., Sobczak I., Meissl K., Weitsman G., Piazzolla D., Maurer G., et al. From autoinhibition to inhibition in trans: the Raf-1 regulatory domain inhibits Rok-alpha kinase activity. Journal of Cell Biology 2009, 187:335-342.
119. Clapéron A., Therrien M. KSR and CNK: two scaffolds regulating RAS-mediated RAF activation. Oncogene 2007, 26:3143-3158.
120. McKay M.M., Freeman A.K., Morrison D.K. Complexity in KSR function revealed by Raf inhibitor and KSR structure studies. Small GTPases 2011, 2:276-281.
121. Yamaguchi O., Watanabe T., Nishida K., Kashiwase K., Higuchi Y., Takeda T., et al. Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis. Journal of Clinical Investigation 2004, 114:937-943.
122. Kilili G.K., Kyriakis J.M. Mammalian Ste20-like kinase (Mst2) indirectly supports Raf-1/ERK pathway activity via maintenance of protein phosphatase-2A catalytic subunit levels and consequent suppression of inhibitory Raf-1 phosphorylation. Journal of Biological Chemistry 2010, 285:15076-15087.
123. Yuan Z., Kim D., Shu S., Wu J., Guo J., Xiao L., et al. Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120. Journal of Biological Chemistry 2010, 285:3815-3824.
124. Jang S.W., Yang S.J., Srinivasan S., Ye K. Akt phosphorylates MstI and prevents its proteolytic activation, blocking FOXO3 phosphorylation and nuclear translocation. Journal of Biological Chemistry 2007, 282:30836-30844.
125. Kim D., Shu S., Coppola M.D., Kaneko S., Yuan Z.Q., Cheng J.Q. Regulation of proapoptotic mammalian ste20-like kinase MST2 by the IGF1-Akt pathway. PLoS One 2010, 5:e9616.
126. Wang H.C., Fecteau K.A. Detection of a novel quiescence-dependent protein kinase. Journal of Biological Chemistry 2000, 275:25850-25857.
127. Romano D., Matallanas D., Weitsman G., Preisinger C., Ng T., Kolch W. Proapoptotic kinase MST2 coordinates signaling crosstalk between RASSF1A, Raf-1, and Akt. Cancer Research 2010, 70:1195-1203.
128. Warfel N.A., Newton A.C. Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling. Journal of Biological Chemistry 2012, 287:3610-3616.
129. Qiao M., Wang Y., Xu X., Lu J., Dong Y., Tao W., et al. Mst1 is an interacting protein that mediates PHLPPs' induced apoptosis. Molecular Cell 2010, 38:512-523.
130. Cinar B., Fang P.K., Lutchman M., Di Vizio D., Adam R.M., Pavlova N., et al. The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1. EMBO Journal 2007, 26:4523-4534.
131. Strassburger K., Tiebe M., Pinna F., Breuhahn K., Teleman A.A. Insulin/IGF signaling drives cell proliferation in part via Yorkie/Yap. Developmental Biology 2012, 367:187-196.
132. Ye X, Deng Y, Lai Z-C. Akt is negatively regulated by Hippo signaling for growth inhibition in Drosophila. Dev Biol; in press, PMID: pmid:22732571.
133. Graves J.D., Draves K.E., Gotoh Y., Krebs E.G., Clark E.A. Both phosphorylation and caspase-mediated cleavage contribute to regulation of the Ste20-like protein kinase Mst1 during CD95/Fas-induced apoptosis. Journal of Biological Chemistry 2001, 276:14909-14915.
134. Ura S., Masuyama N., Graves J.D., Gotoh Y. MST1-JNK promotes apoptosis via caspase-dependent and independent pathways. Genes to Cells 2001, 6:519-530.
135. Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A., et al. Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 2003, 113:507-517.
136. Hu Y., Liu Z., Yang S.J., Ye K. Acinus-provoked protein kinase C delta isoform activation is essential for apoptotic chromatin condensation. Cell Death and Differentiation 2007, 14:2035-2046.
137. Chan E.H., Nousiainen M., Chalamalasetty R.B., Schäfer A., Nigg E.A., Silljé H.H. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 2005, 24:2076-2086.
138. Stegert M.R., Hergovich A., Tamaskovic R., Bichsel S.J., Hemmings B.A. Regulation of NDR protein kinase by hydrophobic motif phosphorylation mediated by the mammalian Ste20-like kinase MST3. Molecular and Cellular Biology 2005, 25:11019-11029.
139. Hergovich A., Stegert M.R., Schmitz D., Hemmings B.A. NDR kinases regulate essential cell processes from yeast to humans. Nature Reviews Molecular Cell Biology 2006, 7:253-264.
140. Bichsel S.J., Tamaskovic R., Stegert M.R., Hemmings B.A. Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein. Journal of Biological Chemistry 2004, 279:35228-35235.
141. Hergovich A., Bichsel S.J., Hemmings B.A. Human NDR kinases are rapidly activated by MOB proteins through recruitment to the plasma membrane and phosphorylation. Molecular and Cellular Biology 2005, 25:8259-8272.
142. Hergovich A., Schmitz D., Hemmings B.A. The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. Biochemical and Biophysical Research Communications 2006, 345:50-58.
143. Pearce L.R., Komander D., Alessi D.R. The nuts and bolts of AGC protein kinases. Nature Reviews Molecular Cell Biology 2010, 11:9-22.
144. Koike-Kumagai M., Yasunaga K., Morikawa R., Kanamori T., Emoto K. The target of rapamycin complex 2 controls dendritic tiling of Drosophila sensory neurons through the Tricornered kinase signalling pathway. EMBO Journal 2009, 28:3879-3892.
145. Geng W., He B., Wang M., Adler P.N. The tricornered gene, which is required for the integrity of epidermal cell extensions, encodes the Drosophila nuclear DBF2-related kinase. Genetics 2000, 156:1817-1828.
146. Fang X., Adler P.N. Regulation of cell shape, wing hair initiation and the actin cytoskeleton by Trc/Fry and Wts/Mats complexes. Developmental Biology 2010, 341:360-374.
147. Cong J., Geng W., He B., Liu J., Charlton J., Adler P.N. The furry gene of Drosophila is important for maintaining the integrity of cellular extensions during morphogenesis. Development 2001, 128:2793-2802.
148. He Y., Fang X., Emoto K., Jan Y.N., Adler P.N. The tricornered Ser/Thr protein kinase is regulated by phosphorylation and interacts with furry during Drosophila wing hair development. Molecular Biology of the Cell 2005, 16:689-700.
149. He Y., Emoto K., Fang X., Ren N., Tian X., Jan Y.N., et al. Drosophila Mob family proteins interact with the related tricornered (Trc) and warts (Wts) kinases. Molecular Biology of the Cell 2005, 16:4139-4152.
150. Chiba S., Ikeda M., Katsunuma K., Ohashi K., Mizuno K. MST2- and Furry-mediated activation of NDR1 kinase is critical for precise alignment of mitotic chromosomes. Current Biology 2009, 19:675-681.
151. Hergovich A., Lamla S., Nigg E.A., Hemmings B.A. Centrosome-associated NDR kinase regulates centrosome duplication. Molecular Cell 2007, 25:625-634.
152. Hergovich A., Kohler R.S., Schmitz D., Vichalkovski A., Cornils H., Hemmings B.A. The MST1 and hMOB1 tumor suppressors control human centrosome duplication by regulating NDR kinase phosphorylation. Current Biology 2009, 19:1692-1702.
153. Hergovich A., Cornils H., Hemmings B.A. Mammalian NDR protein kinases: from regulation to a role in centrosome duplication. Biochimica et Biophysica Acta 2008, 1784:3-15.
154. Hergovich A. MOB control: reviewing a conserved family of kinase regulators. Cellular Signalling 2011, 23:1433-1440.
155. Kohler R.S., Schmitz D., Cornils H., Hemmings B.A., Hergovich A. Differential NDR/LATS interactions with the human MOB family reveal a negative role for human MOB2 in the regulation of human NDR kinases. Molecular and Cellular Biology 2010, 30:4507-4520.
156. Wei X., Shimizu T., Lai Z.C. Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila. EMBO Journal 2007, 26:1772-1778.
157. Côté J.F., Vuori K. GEF what? Dock180 and related proteins help Rac to polarize cells in new ways. Trends in Cell Biology 2007, 17:383-393.
158. Huang H., Tindall D.J. Dynamic FoxO transcription factors. Journal of Cell Science 2007, 120(Pt 15):2479-2487.
159. Paik J.H., Kollipara R., Chu G., Ji H., Xiao Y., Ding Z., et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 2007, 128:309-323.
160. van den Berg M.C., Burgering B.M. Integrating opposing signals toward Forkhead box O. Antioxidants and Redox Signalling 2011, 14:607-621.
161. Boccitto M., Kalb R.G. Regulation of Foxo-dependent transcription by post-translational modifications. Current Drug Targets 2011, 12:1303-1310.
162. Huang H., Tindall D.J. Regulation of FOXO protein stability via ubiquitination and proteasome degradation. Biochimica et Biophysica Acta 2011, 1813:1961-1964.
163. Lehtinen M.K., Yuan Z., Boag P.R., Yang Y., Villén J., Becker E.B., et al. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 2006, 125:987-1001.
164. Yuan Z., Lehtinen M.K., Merlo P., Villén J., Gygi S., Bonni A. Regulation of neuronal cell death by MST1-FOXO1 signaling. Journal of Biological Chemistry 2009, 284:11285-11292.
165. Kenyon C.J. The genetics of ageing. Nature 2010, 464:504-512.
166. Bardin A.J., Amon A. Men and sin: what's the difference?. Nature Reviews Molecular Cell Biology 2001, 2:815-826.
167. Krapp A., Gulli M.P., Simanis V. SIN and the art of splitting the fission yeast cell. Current Biology 2004, 14:R722-R730.
168. Goyal A., Takaine M., Simanis V., Nakano K. Dividing the spoils of growth and the cell cycle: the fission yeast as a model for the study of cytokinesis. Cytoskeleton (Hoboken) 2011, 68:69-88.
169. Rock J.M., Amon A. Cdc15 integrates Tem1 GTPase-mediated spatial signals with Polo kinase-mediated temporal cues to activate mitotic exit. Genes and Development 2011, 25:1943-1954.